Replimune Group, Inc. (REPL)

5.22 +0.29 (+5.88%) USD  |  NASDAQ  |  May 15, 16:00
5.18 -0.04 (-0.77%) After-Hours: 20:00
More

Replimune Group EPS Diluted (Quarterly YoY Growth)

EPS Diluted (Quarterly YoY Growth) Chart

View EPS Diluted (Quarterly YoY Growth) for REPL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years

View EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly YoY Growth) Benchmarks

View EPS Diluted (Quarterly YoY Growth) Benchmarks
Start Trial
REGENXBIO, Inc. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade
Spyre Therapeutics, Inc. Upgrade
Bristol Myers Squibb Co. Upgrade
ANI Pharmaceuticals, Inc. Upgrade